Compounded Tirzepatide
Check whether compounded Tirzepatide can be routed, what restrictions may apply, and what to ask your prescriber or pharmacist.
About Tirzepatide
Compounded tirzepatide is a dual GIP/GLP-1 receptor agonist available through licensed U.S. 503A/503B pharmacies only when a prescriber documents a specific clinical reason the commercial product (Mounjaro, Zepbound) is not appropriate — for example, a documented allergy to an inactive ingredient or a need for a non-commercial strength. Following the FDA's 2024 resolution of the tirzepatide shortage, compounded tirzepatide is no longer available for supply or cost reasons.
Current legal status of compounded tirzepatide (2026)
As of 2026, compounded tirzepatide is not legal under the shortage-based exception that was in effect in 2023–2024. The FDA declared the tirzepatide shortage resolved in late 2024, removing the basis for 503A pharmacies to compound widely distributed copies of Mounjaro or Zepbound.
Compounding is still permitted on a case-by-case basis under Section 503A when a prescriber documents a specific clinical reason the commercial product is not appropriate for the patient. Cost alone is not a valid basis for compounding. A pharmacy offering widely distributed compounded tirzepatide without documented clinical need is operating outside FDA guidance.
When compounded tirzepatide is clinically appropriate
Documented clinical reasons that may justify compounded tirzepatide include: allergies or intolerances to polysorbate, benzyl alcohol, phenol, or other excipients in the branded products; a need for a non-commercial strength to support a titration or tapering protocol that the commercial fixed-dose pens cannot match; or other medically documented circumstances.
Your prescriber must document the reason in your chart and on the prescription. A compounding pharmacy cannot fill a compounded tirzepatide prescription without that documentation — this is a Section 503A legal requirement, not a company policy.
Commercial tirzepatide products — the typical right answer
For most patients, the commercial branded products are the correct choice: Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved for chronic weight management). Both are manufactured by Eli Lilly under strict quality controls and covered by many commercial insurance plans for appropriate indications.
Eli Lilly's LillyDirect direct-pay program offers Zepbound at reduced monthly costs for cash-pay patients, and the Zepbound Savings Card can reduce out-of-pocket costs with commercial insurance. If your prescriber does not have a documented clinical reason to compound, the commercial product plus manufacturer programs is the appropriate path.
Key Questions About Tirzepatide
Can I get Tirzepatide compounded?
Not through Compounding Finder right now. A prescriber and pharmacist still have to decide whether any compounded Tirzepatide preparation is legally and clinically appropriate.
Will Compounding Finder send my Tirzepatide request to pharmacies?
No. Compounding Finder is not sending Tirzepatide quote requests to pharmacies at this time, so we cannot return Tirzepatide quotes or prices. If FDA guidance changes, we will revisit.
Source notes: FDA explains that compounded drugs are not FDA-approved finished products and describes 503A compounding around patient-specific prescriptions. See Compounding and the FDA and Section 503A.
Frequently Asked Questions
Is compounded tirzepatide legal after the FDA shortage resolution?
Compounded tirzepatide is legal only on a case-by-case basis under Section 503A — for example, when a prescriber documents that the patient has an allergy to an inactive ingredient in Mounjaro or Zepbound, or needs a non-commercial strength for a documented clinical reason. The shortage-based exception that allowed widely distributed compounding in 2023–2024 ended when the FDA declared the tirzepatide shortage resolved in late 2024. Cost alone is not a valid basis for compounding.
Can I get compounded tirzepatide cheaper than Zepbound?
No — under FDA rules, cost is not a valid clinical reason to compound a drug that is commercially available. A prescriber must document a specific clinical reason for a compounded version to be appropriate. Eli Lilly's LillyDirect program offers Zepbound at reduced out-of-pocket cost for cash-pay patients and is the appropriate path for most cost-sensitive patients — not compounding.
What's the difference between compounded tirzepatide and Mounjaro?
Mounjaro is an FDA-approved branded tirzepatide product manufactured by Eli Lilly under strict quality controls. Compounded tirzepatide is prepared by a licensed pharmacist under state pharmacy compounding standards and is not FDA-evaluated for batch safety or efficacy. The active ingredient can be the same, but compounded versions may differ in excipients, concentration, storage requirements, and potency tolerance. Compounded versions should only be used when the commercial branded product is clinically inappropriate for a specific patient.
How do I verify a tirzepatide pharmacy is legitimate?
Verify the pharmacy is licensed in your state through your state board of pharmacy, confirm they hold a compounding permit, and ask whether they are inspected by PCAB (Pharmacy Compounding Accreditation Board) or registered as a 503B outsourcing facility. Avoid any seller that ships tirzepatide without a prescription, non-U.S. online pharmacies, or any vendor marketing peptides as "research chemicals." Compounding Finder only works with licensed U.S. compounding pharmacies.
We Do Not Currently Route Tirzepatide Quote Requests
Tirzepatide (Mounjaro / Zepbound) was removed from the FDA drug shortage list, so a compounding pharmacy can only prepare it when there is a specific, documented medical reason the brand will not work. If FDA guidance changes, we will revisit.
What actually works instead
The compliant path is the manufacturer's own pharmacy. Ask your prescriber to send the prescription there, or check your insurance coverage.
- Zepbound through LillyDirect
Ask your prescriber to send your Zepbound prescription electronically to “LillyDirect Self Pay Pharmacy Solutions.” LillyDirect handles payment and ships to your home directly.
Get Zepbound at LillyDirect → - Compounded semaglutide and tirzepatide: what changed
What the rules actually say, why pharmacies stopped, and the legitimate lower-cost paths that still exist.
See your real options for semaglutide & tirzepatide →
Links to external price-comparison tools and retail pharmacies are provided for convenience. Compounding Finder is not affiliated with these services and does not receive information about your purchases. Always consult your prescriber before changing medications.